Pharmacoeconomic benefit of a patient-oriented automated drug distribution system combined with intensive advisory services

Bernd Meibohm, T. Garms, K. Meier, S. Melzer, S. Schwarz

Research output: Contribution to journalArticle

Abstract

The pharmacy department of General Hospital Harburg, Hamburg, Germany, started a pilot project to evaluate the benefit of the implementation of a patient-oriented automated unit dose drug distribution system in combination with intensive advisory services. Three wards with nearly 100 beds were included. After eight months, the benefit of the project was estimated in a preliminary report. Logistical, as well as therapeutic advantages could be detected. The development of drug costs and length of stay were used as quantitative parameters for cost and outcome. Both could be reduced on all three wards, with mean values of -26.7% and -8.2% for drug costs and length of stay, respectively. On reference wards supplied with the traditional distribution system, the respective values were +4.9% and +6.9%. It was concluded that the combination of innovative drug distribution systems and patient focused advisory services are powerful instruments to save financial resources with a simultaneous improvement of therapeutic quality.

Original languageEnglish (US)
Pages (from-to)343-349
Number of pages7
JournalJournal of Applied Therapeutics
Volume1
Issue number4
StatePublished - Dec 1 1997
Externally publishedYes

Fingerprint

Pharmaceutical Economics
Drug Costs
Consultants
Length of Stay
Medication Systems
Drug Combinations
Quality Improvement
General Hospitals
Pharmaceutical Preparations
Germany
Costs and Cost Analysis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Pharmacoeconomic benefit of a patient-oriented automated drug distribution system combined with intensive advisory services. / Meibohm, Bernd; Garms, T.; Meier, K.; Melzer, S.; Schwarz, S.

In: Journal of Applied Therapeutics, Vol. 1, No. 4, 01.12.1997, p. 343-349.

Research output: Contribution to journalArticle

@article{58b85d7c88dc40e99700a7aa2f723733,
title = "Pharmacoeconomic benefit of a patient-oriented automated drug distribution system combined with intensive advisory services",
abstract = "The pharmacy department of General Hospital Harburg, Hamburg, Germany, started a pilot project to evaluate the benefit of the implementation of a patient-oriented automated unit dose drug distribution system in combination with intensive advisory services. Three wards with nearly 100 beds were included. After eight months, the benefit of the project was estimated in a preliminary report. Logistical, as well as therapeutic advantages could be detected. The development of drug costs and length of stay were used as quantitative parameters for cost and outcome. Both could be reduced on all three wards, with mean values of -26.7{\%} and -8.2{\%} for drug costs and length of stay, respectively. On reference wards supplied with the traditional distribution system, the respective values were +4.9{\%} and +6.9{\%}. It was concluded that the combination of innovative drug distribution systems and patient focused advisory services are powerful instruments to save financial resources with a simultaneous improvement of therapeutic quality.",
author = "Bernd Meibohm and T. Garms and K. Meier and S. Melzer and S. Schwarz",
year = "1997",
month = "12",
day = "1",
language = "English (US)",
volume = "1",
pages = "343--349",
journal = "Journal of Applied Therapeutics",
issn = "1072-1754",
publisher = "Harwood Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Pharmacoeconomic benefit of a patient-oriented automated drug distribution system combined with intensive advisory services

AU - Meibohm, Bernd

AU - Garms, T.

AU - Meier, K.

AU - Melzer, S.

AU - Schwarz, S.

PY - 1997/12/1

Y1 - 1997/12/1

N2 - The pharmacy department of General Hospital Harburg, Hamburg, Germany, started a pilot project to evaluate the benefit of the implementation of a patient-oriented automated unit dose drug distribution system in combination with intensive advisory services. Three wards with nearly 100 beds were included. After eight months, the benefit of the project was estimated in a preliminary report. Logistical, as well as therapeutic advantages could be detected. The development of drug costs and length of stay were used as quantitative parameters for cost and outcome. Both could be reduced on all three wards, with mean values of -26.7% and -8.2% for drug costs and length of stay, respectively. On reference wards supplied with the traditional distribution system, the respective values were +4.9% and +6.9%. It was concluded that the combination of innovative drug distribution systems and patient focused advisory services are powerful instruments to save financial resources with a simultaneous improvement of therapeutic quality.

AB - The pharmacy department of General Hospital Harburg, Hamburg, Germany, started a pilot project to evaluate the benefit of the implementation of a patient-oriented automated unit dose drug distribution system in combination with intensive advisory services. Three wards with nearly 100 beds were included. After eight months, the benefit of the project was estimated in a preliminary report. Logistical, as well as therapeutic advantages could be detected. The development of drug costs and length of stay were used as quantitative parameters for cost and outcome. Both could be reduced on all three wards, with mean values of -26.7% and -8.2% for drug costs and length of stay, respectively. On reference wards supplied with the traditional distribution system, the respective values were +4.9% and +6.9%. It was concluded that the combination of innovative drug distribution systems and patient focused advisory services are powerful instruments to save financial resources with a simultaneous improvement of therapeutic quality.

UR - http://www.scopus.com/inward/record.url?scp=0031398722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031398722&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031398722

VL - 1

SP - 343

EP - 349

JO - Journal of Applied Therapeutics

JF - Journal of Applied Therapeutics

SN - 1072-1754

IS - 4

ER -